Specialised Products

K-Beauty Products

K-beauty is a market origin, not a product type. A Korean cosmetic, however compliant in Korea, is a new product when imported into the UK or EU and must meet the domestic regime in full, and Korea's ingredient lists do not match the EU's.

K-beauty is a market origin rather than a product type, covering everything from cushion compacts and essences to sheet masks and elaborate multi-step routines. The regulatory point is simple but frequently missed: a Korean cosmetic, however well it complies in Korea, is treated as a new product when it is imported into the UK or EU, and Korea’s ingredient lists are not the same as the EU’s.

Compliant in Korea is not compliant here

Importing a K-beauty product into the UK or EU requires the full domestic set: a Cosmetic Product Safety Report, a Responsible Person established in the market, a notification through SCPN or CPNP, and a label compliant with Article 19 in the correct language. Korean documentation and approvals do not transfer. Whoever brings the product in is the importer and, unless another established party holds the role, the Responsible Person, which is a duty many distributors of K-beauty acquire without realising it.

Ingredient divergence

Korea operates its own positive and negative ingredient lists, administered by the Ministry of Food and Drug Safety, and they do not align with the EU’s. Some UV filters, colorants and functional actives that Korea permits are not on the EU positive lists, and permitted concentrations differ, so a formula legal in Korea can be restricted or prohibited here. Sunscreens are the classic example, because the two markets approve different UV filters, and a celebrated Korean SPF product can fail an EU check on its filter alone. Every formula therefore needs an ingredient-by-ingredient review against the EU and UK annexes.

Functional cosmetics

Korea has a distinct “functional cosmetics” category, covering whitening, anti-wrinkle and UV protection among others, reviewed by the Ministry of Food and Drug Safety. Those functions do not map neatly onto the EU and UK system: some are cosmetic claims that need substantiation here, and some edge towards the borderline, so the claims have to be re-evaluated rather than carried across from the Korean approval.

Formats and labelling

K-beauty’s novel formats, ampoules, cushions, hydrogel masks and the rest, need their packaging and exposure assessed, and the ingredient list, fragrance-allergen declarations and period-after-opening have to be rebuilt to the EU and UK requirements rather than translated from the Korean label.

How we help

We take a K-beauty product through the full domestic process, the CPSR, the Responsible Person role, the notification and the label, run the ingredient-by-ingredient check against the EU and UK annexes, flag where a UV filter or active needs substituting, and re-evaluate the functional claims for these markets. The aim is a K-beauty range that can be sold here lawfully rather than detained or delisted on an ingredient.

Relevant services

📋

CPSR

From £70 · 2 to 3 days

The Cosmetic Product Safety Report is the safety assessment required under Article 10 and Annex I of Regulation (EC) No 1223/2009 before a cosmetic product may be placed on the UK or EU market. Prepared and signed by a qualified safety assessor.

Learn more →
👤

Responsible Person

From £149 · per product, per year

Oxford Biosciences acts as your Responsible Person in the UK and the EU under a single quality management system, holding the regulatory obligation: PIF maintenance, SCPN and CPNP notification, labelling oversight, and cosmetovigilance.

Learn more →
🌍

Global Markets

From £149

Cosmetic regulatory documentation for markets beyond the EU and UK: Canada, Australia, New Zealand, ASEAN, the GCC and Latin America, prepared from the same evidence base by the assessor who signs our CPSRs.

Learn more →

Frequently asked questions

What is needed to import Korean (K-beauty) cosmetics into the UK or EU?

The full domestic set regardless of Korean compliance: a CPSR, a Responsible Person, an SCPN or CPNP notification, and an Article 19 label in the correct language. The importer is the Responsible Person unless another established party holds the role, and the formula must be checked against the EU and UK ingredient lists.

Why might a K-beauty product not be compliant in the EU?

Korea operates its own ingredient lists, administered by the Ministry of Food and Drug Safety, that do not match the EU's. Some UV filters, colorants and actives permitted in Korea are not on the EU positive lists, and concentration limits differ, so a popular Korean product can fail an EU check on a single ingredient.

What is a CPSR?

A Cosmetic Product Safety Report (CPSR) is the safety assessment required by Article 10 and Annex I of Regulation (EC) No 1223/2009 before a cosmetic product is placed on the UK or EU market. Annex I sets out two parts: Part A, the cosmetic product safety information (composition, physico-chemical and microbiological characteristics, stability, exposure and the toxicological profile of each substance), and Part B, the safety assessment, in which a qualified assessor states and reasons the conclusion on safety. It is the pivotal scientific document held within the Product Information File.

What must appear on a cosmetic label?

Article 19 of Regulation (EC) No 1223/2009 sets out the mandatory particulars: the Responsible Person's name and address, the nominal content, the date of minimum durability or the period-after-opening (PAO) symbol, precautions for use, the batch number, the product function, and the list of ingredients in INCI nomenclature. In Great Britain the same requirements apply through the Cosmetic Products Enforcement Regulations 2013, and since 1 January 2026 the UK Responsible Person's details must appear on the label of products sold in GB. Oxford Biosciences reviews packaging artwork against these requirements for £195.

What are the EU restrictions on sunscreen UV filters?

In the EU, only UV filters listed in Annex VI may be used, at set limits. Homosalate is now restricted to face products at 7.34% (Regulation 2022/2195), and benzophenone-3 and octocrylene were cut by Regulation 2022/1176 (BP-3 to 6% face / 2.2% body). 4-MBC is banned. Nanoform filters need Article 16 notification.

Get a quote →
TALK TO US
Questions about CPSRs, MoCRA or Labelling? Ask us anything!